CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale EVP, CFO & Treasurer sold 4,141 shares at $3.40 ($14,079)
- 4 Open-market sale President and CEO sold 3,950 shares at $3.40 ($13,430)
- 4 Open-market sale President and CEO sold 3,922 shares at $3.27 ($12,825)
- 4 Open-market sale President and CEO sold 3,490 shares at $5.17 ($18,043)
- 4 Open-market sale President and CEO sold 3,493 shares at $4.54 ($15,858)
- 4 Open-market sale President and CEO sold 3,488 shares at $5.87 ($20,475)
- 4 Open-market sale President and CEO sold 3,479 shares at an average $5.23 ($18,196)
- 4 Grant or award SVP, Chief Business Officer acquired 20,000 shares (grant or award)
- 4 Grant or award SVP, General Counsel&Secretary acquired 20,000 shares (grant or award)
- 4 Grant or award EVP & Chief Commercial Officer acquired 30,000 shares (grant or award)
- 4 Grant or award EVP, CFO & Treasurer acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 7,576 shares (option exercise)
- 4 Open-market sale President and CEO sold 2,314 shares at $4.48 ($10,367)
- 4 Open-market sale President and CEO sold 2,115 shares at $5.18 ($10,948)
- 4 Open-market sale Chief Commercial Officer sold 1,551 shares at an average $5.21 ($8,075)
- 4 Open-market sale Director sold 538,784 shares at an average $6.38 ($3,434,798)
- 4 Open-market sale President and CEO sold 2,542 shares at $5.76 ($14,642)
- 4 Open-market sale EVP, CFO, Treasurer sold 601 shares at an average $6.04 ($3,630)
- 4 Derivatives Options or other derivatives
Page 9 of 31 · 601 filings